Treatment of SM102 significantly increased tear production and breakup time of tear film in diabetic DES mice, which could be the basis of SM102 treatment on diabetic DES
Clinical trial data from the STEP program showed participants lost an average of 14.9% of their body weight over 68 weeks
International markets, particularly Brazil and China, could see rapid expansion as affordability improves through generics
Regarding lactation, there are no data on tirzepatide presence in human milk, effects on the breastfed infant, or effects on milk production
AOD9604 is a peptide therapy often called the fat-burning peptide, derived from the C-terminus of human growth hormone, meaning the tail end of the molecule
Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial